Towards early detection and disease interception of COPD across the lifespan
Understanding the Heterogeneity and Burden of COPD
COPD is “a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnoea, cough, sputum production and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction”.
COPD is a major public health problem worldwide. It is the third cause of death globally, affects about 10% of the adult population, is associated with significant morbidity and mortality, and has a huge impact on patients, their families and society.
Shifting Paradigms in COPD Pathogenesis
Our understanding of the pathogenesis of COPD has changed significantly over the past few years.
We review how this new knowledge can inform future clinical strategies directed towards earlier detection and disease interception of COPD across the lifespan, thus reducing its disease burden and improving the well-being and prognosis of COPD patients.
Future Directions and Research Opportunities
This review highlights that our understanding of, and ability to prevent and treat, chronic airway diseases, particularly COPD, is entering a new era.
There are still many questions to be answered, but there are great opportunities for research and, more importantly, to improve the well-being and prognosis of these patients.
Authors
Rosa Faner, Michael H. Cho, Gerard H. Koppelman, Erik Melén, Stijn E. Verleden, Shyamali C. Dharmage, Silke Meiners, Alvar Agusti
Read more details at
Fecha de publicación
9 July 2025
Categorías asociadas al artículo
Noticias relacionadas
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry to diagnose of COPD
Siprometry to diagnose COPD: GOLD 2025 recommends using pre-BD spirometry to rule out COPD and post-BD to confirm, ensuring volume responders are not overlooked.
Treatable traits in pre-COPD: Time to extend the treatable traits paradigm beyond established disease
Explore how the treatable traits approach can be applied to pre-COPD, potentially preventing full disease development. Learn about GETomics and its role in understanding pre-COPD through gene-environment interactions.
Impact of Ex Vivo Lung Perfusion System on the Lung Microbiome
Discover how ex vivo lung perfusion (EVLP) impacts the lung microbiome and its implications for improving donor lung viability and reducing transplant complications.
Metabolomic Plasma Profile of Chronic Obstructive Pulmonary Disease Patients
This study identifies a metabolic signature of COPD patients, involving fatty acids, amino acid and carbohydrate metabolites, using LC-MS plasma profiling.
General population-based lung function trajectories over the life course: an accelerated cohort study
Empirical life course lung function trajectories from ages 4–80 using data from eight cohort studies in Europe and Australia.
Residential greenspace and lung function throughout childhood and adolescence in five European birth cohorts. A CADSET initiative
Study of five European cohorts found no association between residential greenness or urban green space and lung function throughout childhood and adolescence.
Imagen desarrollada por IA